在西班牙家庭中,血液静止表型的遗传决定因素
J C Souto1, L Almasy, M Borrell
1Unit of Thrombosis and Hemostasis, Department of Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Circulation
|April 4, 2000
概括
遗传因素显著影响与血静相关的特征,影响血栓形成风险. 这项研究量化了对这些凝血和纤维素分解表型的遗传贡献.
科学领域:
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
- 血栓形成研究研究
背景情况:
- 通过血静参数 (蛋白C,蛋白S,活性蛋白C抵抗比率) 与血栓形成风险相关的遗传突变.
- 以前的研究表明,基因对血静有影响,但相对重要性仍未得到评估.
研究的目的:
- 量化遗传和环境因素对与血静相关的表型的相对贡献.
- 评估各种血液静止措施的遗传性及其与血栓形成风险的关联.
主要方法:
- 在21个扩展的血统中分析了397个个体的27种与静血相关的表型.
- 共同变量 (性别,年龄,吸烟,荷尔蒙),基因和共同的环境因素的量化影响.
- 计算了每个表型的遗传概率估计.
主要成果:
- 所有评估的表型都显示出显著的遗传贡献.
- 继承率估计在同变量校正后从22%到55%不等.
- 活性蛋白C抵抗比率 (71.3%),活性部分血栓形成时间 (83.0%) 和XII因子 (67.3%) 的遗传性最高.
结论:
- 遗传因素在凝血和纤维溶解途径内的血液静止表型变异中起着至关重要的作用.
- 这些发现突出了识别影响血栓形成风险的新基因的潜力.
- 强烈的遗传效应为局部基因铺平了道路,影响了与血栓形成相关的定量血静特征.
相关概念视频
Genetic Lingo
Overview
Pedigree Analysis
Overview
Background and Environment Affect Phenotype
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...


